Point-of-care Infectious Disease Diagnostics
Market
Point-of-care Infectious Disease Diagnostics Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Point-of-care Infectious Disease Diagnostics Market
Size and Growth
The Point-of-Care Infectious Disease Diagnostics market is experiencing robust growth, driven by increasing demand for rapid testing and the rise of infectious diseases. The market size is projected to reach approximately $3 billion by 2025, influenced by innovations in technology and a focus on decentralized healthcare solutions.
Companies Covered
(Covid 19 Impact Covered)
◍ Thermo Fisher Scientific
◍ Abbott
◍ Calypte Biomedical
◍ Chembio Diagnostic Systems
◍ Meridian Bioscience
◍ MedMira
◍ Trinity Biotech
◍ Sekisui Diagnostics
◍ OraSure Technologies
◍ Quidel
The Point-of-care Infectious Disease Diagnostics Market features key players like Thermo Fisher Scientific, Abbott, and Quidel, offering innovative testing solutions. Companies enhance market growth by providing rapid diagnostics, expanding product portfolios, and improving accessibility. Notable sales figures include Abbott's diagnostics revenue at approximately $8 billion in 2020.
Request Sample Report
Market Segmentation
By Application
◍ Clinics
◍ Home
◍ Assisted Living Healthcare Facilities
◍ Laboratories
◍ Others
By Product
TB and Drug-Resistant TB POC ◍ Hospitals
◍ HIV POC ◍ Clostridium Difficile POC ◍ HBV POC ◍ Respiratory Syncytial Virus POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
